A liposomal formulation of irinotecan (Irinophore CTM) decreased both the density of tumour cells and tumour vasculature (CD31+) cells in subcutaneous colorectal tumours of mice treated weekly for 6 weeks, when compared to saline-treated mice [165]. This evidence concerns the gene PECAM1 and neoplasm.